| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Revenue | $2.3M | -32.7% |
| Cost of Revenue | $2.1M | -20.5% |
| Gross Profit | $156K | -78.3% |
| R&D Expense | $9.3M | -35.0% |
| SG&A Expense | $19.8M | -31.1% |
| Operating Income | -$29.6M | +29.9% |
| Pre-tax Income | -$33.5M | +26.6% |
| Income Tax | $4K | +100.0% |
| Net Income | -$33.5M |
| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.7M | -81.0% |
| Accounts Receivable | $722K | -7.0% |
| Current Assets | $6.1M | -77.2% |
| Total Assets | $8.0M | -74.0% |
| Current Liabilities | $11.5M | -28.8% |
| Total Liabilities | $15.8M | -33.1% |
| Stockholders' Equity | -$7.9M | -212.7% |
| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$30.1M | +11.7% |
| Investing Cash Flow | -$4K | — |
| Financing Cash Flow | $10.3M | -37.4% |
| +26.6% |
| EPS (Basic) | -$0.31 | +43.6% |
| EPS (Diluted) | -$0.31 | +43.6% |